Literature DB >> 31289210

TP53, ETV6 and RUNX1 germline variants in a case series of patients developing secondary neoplasms after treatment for childhood acute lymphoblastic leukemia.

Stefanie V Junk1, Norman Klein1, Sabine Schreek1, Martin Zimmermann1, Anja Möricke2, Kirsten Bleckmann2, Julia Alten2, Elif Dagdan1,3, Gunnar Cario2, Christian P Kratz1, Martin Schrappe2, Martin Stanulla4.   

Abstract

Entities:  

Year:  2019        PMID： 31289210      PMCID： PMC6717588          DOI： 10.3324/haematol.2018.205849

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  16 in total

1.  Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.

Authors:  A Möricke; M Zimmermann; A Reiter; H Gadner; E Odenwald; J Harbott; W-D Ludwig; H Riehm; M Schrappe
Journal:  Klin Padiatr       Date:  2005 Nov-Dec       Impact factor: 1.349

2.  TP53 mutations are frequent in adult acute lymphoblastic leukemia cases negative for recurrent fusion genes and correlate with poor response to induction therapy.

Authors:  Sabina Chiaretti; Fulvia Brugnoletti; Simona Tavolaro; Silvia Bonina; Francesca Paoloni; Marilisa Marinelli; Nancy Patten; Massimiliano Bonifacio; Maria Grazia Kropp; Simona Sica; Anna Guarini; Robin Foà
Journal:  Haematologica       Date:  2013-02-12       Impact factor: 9.941

3.  Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy.

Authors:  Michael Y Zhang; Jane E Churpek; Siobán B Keel; Tom Walsh; Ming K Lee; Keith R Loeb; Suleyman Gulsuner; Colin C Pritchard; Marilyn Sanchez-Bonilla; Jeffrey J Delrow; Ryan S Basom; Melissa Forouhar; Boglarka Gyurkocza; Bradford S Schwartz; Barbara Neistadt; Rafael Marquez; Christopher J Mariani; Scott A Coats; Inga Hofmann; R Coleman Lindsley; David A Williams; Janis L Abkowitz; Marshall S Horwitz; Mary-Claire King; Lucy A Godley; Akiko Shimamura
Journal:  Nat Genet       Date:  2015-01-12       Impact factor: 38.330

4.  Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia.

Authors:  Jana Hof; Stefanie Krentz; Claudia van Schewick; Gabriele Körner; Shabnam Shalapour; Peter Rhein; Leonid Karawajew; Wolf-Dieter Ludwig; Karl Seeger; Günter Henze; Arend von Stackelberg; Christian Hagemeier; Cornelia Eckert; Renate Kirschner-Schwabe
Journal:  J Clin Oncol       Date:  2011-07-11       Impact factor: 44.544

5.  Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000.

Authors:  A Möricke; M Zimmermann; A Reiter; G Henze; A Schrauder; H Gadner; W D Ludwig; J Ritter; J Harbott; G Mann; T Klingebiel; F Zintl; C Niemeyer; B Kremens; F Niggli; D Niethammer; K Welte; M Stanulla; E Odenwald; H Riehm; M Schrappe
Journal:  Leukemia       Date:  2009-12-10       Impact factor: 11.528

6.  The genomic landscape of hypodiploid acute lymphoblastic leukemia.

Authors:  Linda Holmfeldt; Lei Wei; Ernesto Diaz-Flores; Michael Walsh; Jinghui Zhang; Li Ding; Debbie Payne-Turner; Michelle Churchman; Anna Andersson; Shann-Ching Chen; Kelly McCastlain; Jared Becksfort; Jing Ma; Gang Wu; Samir N Patel; Susan L Heatley; Letha A Phillips; Guangchun Song; John Easton; Matthew Parker; Xiang Chen; Michael Rusch; Kristy Boggs; Bhavin Vadodaria; Erin Hedlund; Christina Drenberg; Sharyn Baker; Deqing Pei; Cheng Cheng; Robert Huether; Charles Lu; Robert S Fulton; Lucinda L Fulton; Yashodhan Tabib; David J Dooling; Kerri Ochoa; Mark Minden; Ian D Lewis; L Bik To; Paula Marlton; Andrew W Roberts; Gordana Raca; Wendy Stock; Geoffrey Neale; Hans G Drexler; Ross A Dickins; David W Ellison; Sheila A Shurtleff; Ching-Hon Pui; Raul C Ribeiro; Meenakshi Devidas; Andrew J Carroll; Nyla A Heerema; Brent Wood; Michael J Borowitz; Julie M Gastier-Foster; Susana C Raimondi; Elaine R Mardis; Richard K Wilson; James R Downing; Stephen P Hunger; Mignon L Loh; Charles G Mullighan
Journal:  Nat Genet       Date:  2013-01-20       Impact factor: 38.330

7.  Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols.

Authors:  Martin Stanulla; Elke Schaeffeler; Anja Möricke; Sally A Coulthard; Gunnar Cario; André Schrauder; Peter Kaatsch; Michael Dördelmann; Karl Welte; Martin Zimmermann; Alfred Reiter; Michel Eichelbaum; Hansjörg Riehm; Martin Schrappe; Matthias Schwab
Journal:  Blood       Date:  2009-06-17       Impact factor: 22.113

8.  Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia.

Authors:  Kjeld Schmiegelow; Mette Frandsen Levinsen; Andishe Attarbaschi; Andre Baruchel; Meenakshi Devidas; Gabriele Escherich; Brenda Gibson; Christiane Heydrich; Keizo Horibe; Yasushi Ishida; Der-Cherng Liang; Franco Locatelli; Gérard Michel; Rob Pieters; Caroline Piette; Ching-Hon Pui; Susana Raimondi; Lewis Silverman; Martin Stanulla; Batia Stark; Naomi Winick; Maria Grazia Valsecchi
Journal:  J Clin Oncol       Date:  2013-05-20       Impact factor: 44.544

9.  Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia.

Authors:  Leila Noetzli; Richard W Lo; Walter H A Kahr; Christopher C Porter; Jorge Di Paola; Alisa B Lee-Sherick; Michael Callaghan; Patrizia Noris; Anna Savoia; Madhvi Rajpurkar; Kenneth Jones; Katherine Gowan; Carlo Balduini; Alessandro Pecci; Chiara Gnan; Daniela De Rocco; Michael Doubek; Ling Li; Lily Lu; Richard Leung; Carolina Landolt-Marticorena; Stephen Hunger; Paula Heller; Arthur Gutierrez-Hartmann; Liang Xiayuan; Fred G Pluthero; Jesse W Rowley; Andrew S Weyrich
Journal:  Nat Genet       Date:  2015-03-25       Impact factor: 38.330

10.  SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information.

Authors:  Marco Biasini; Stefan Bienert; Andrew Waterhouse; Konstantin Arnold; Gabriel Studer; Tobias Schmidt; Florian Kiefer; Tiziano Gallo Cassarino; Martino Bertoni; Lorenza Bordoli; Torsten Schwede
Journal:  Nucleic Acids Res       Date:  2014-04-29       Impact factor: 16.971
View more
  3 in total

1.  Predisposition to childhood acute lymphoblastic leukemia caused by a constitutional translocation disrupting ETV6.

Authors:  Tekla Järviaho; Benedicte Bang; Vasilios Zachariadis; Fulya Taylan; Jukka Moilanen; Merja Möttönen; C I Edvard Smith; Arja Harila-Saari; Riitta Niinimäki; Ann Nordgren
Journal:  Blood Adv       Date:  2019-09-24

2.  Spectrum of gene mutations identified by targeted next-generation sequencing in Chinese leukemia patients.

Authors:  Hongxia Yao; Congming Wu; Yueqing Chen; Li Guo; Wenting Chen; Yanping Pan; Xiangjun Fu; Guyun Wang; Yipeng Ding
Journal:  Mol Genet Genomic Med       Date:  2020-07-07       Impact factor: 2.183

3.  NUDT15 variants confer high incidence of second malignancies in children with acute lymphoblastic leukemia.

Authors:  Masanori Yoshida; Kazuhiko Nakabayashi; Wentao Yang; Aiko Sato-Otsubo; Shin-Ichi Tsujimoto; Hiroko Ogata-Kawata; Tomoko Kawai; Keisuke Ishiwata; Mika Sakamoto; Kohji Okamura; Kaoru Yoshida; Ryota Shirai; Tomoo Osumi; Takaya Moriyama; Rina Nishii; Hiroyuki Takahashi; Chikako Kiyotani; Yoko Shioda; Keita Terashima; Sae Ishimaru; Yuki Yuza; Masatoshi Takagi; Yuki Arakawa; Akitoshi Kinoshita; Moeko Hino; Toshihiko Imamura; Daisuke Hasegawa; Yozo Nakazawa; Mayuko Okuya; Harumi Kakuda; Nao Takasugi; Akiko Inoue; Kentaro Ohki; Takako Yoshioka; Shuichi Ito; Daisuke Tomizawa; Katsuyoshi Koh; Kimikazu Matsumoto; Masashi Sanada; Nobutaka Kiyokawa; Akira Ohara; Seishi Ogawa; Atsushi Manabe; Akira Niwa; Kenichiro Hata; Jun J Yang; Motohiro Kato
Journal:  Blood Adv       Date:  2021-12-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.